Home › Ewing Sarcoma › Minnesota › Minneapolis
Ewing Sarcoma clinical trials in Minneapolis, MN
3 studies for Ewing Sarcoma are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
Recruiting
- University of Minnesota, Minneapolis
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RecruitingPhase 1/2
- Children's Hospital and Clinics of Minn, Minneapolis
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Philadelphia, PA7 studies
- Houston, TX7 studies
- Memphis, TN7 studies
- Boston, MA6 studies
- Los Angeles, CA6 studies
- Aurora, CO6 studies
- Washington, DC6 studies
- Birmingham, AL5 studies
- Atlanta, GA5 studies
- Phoenix, AZ4 studies
- Cincinnati, OH4 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer23 studies
- Ovarian Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Endometrial Cancer19 studies
- Colorectal Cancer19 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.